|
Written by Editorial Staff
The uptake of the radiopharmaceutical fluoro methyl tyrosine (FMT) on PET imaging in patients with pulmonary adenocarcinoma is a significant independent predictor of poor prognosis, according to research published in this month’s issue of the Journal of Nuclear Medicine.
Preoperative staging with PET/CT and cranial imaging identified more patients with mediastinal and extrathoracic disease than conventional staging, thereby sparing more patients from stage-inappropriate surgery, but the strategy also incorrectly upstaged disease in more patients, according to a randomized trial in the Aug. 18 issue of the Annals of Internal Medicine.
Written by Justine Cadet
The use of PET/CT for preoperative staging of non-small-cell lung cancer reduced both the total number of thoracotomies and the number of futile thoracotomies but did not affect overall mortality, according to a study in the July 2 issue of the New England Journal of Medicine.
|
A PET tracer--3'-deoxy-3'-(18) F-fluorothymidine ([18] F-FLT)--could monitor changes in cellular proliferation of non-small-cell lung cancer (NSCLC) during radical chemo-radiotherapy, according to research published April 20 in the online edition of International Journal of Radiation Oncology, Biology, Physics.
Radiotherapy plus chemotherapy, with or without surgery, are both treatment options for patients with stage IIIA (N2) non-small cell lung cancer (NSCLC), according to research published online July 26 in Lancet.
Although expensive compared with CT, serial 18F-FDG PET could have practical value by facilitating response-adapted therapy and could actually reduce overall healthcare costs by leading to more cures and diminishing the use of and complications associated with ineffective treatment, according to a review of PET assessment of non-small cell lung cancer (NSCLC) in the May supplement issue of the Journal of Nuclear Medicine.
|
RSS 
The use of health IT to reduce rehospitalizations will be welcome but also disruptive, said Stephen Jencks, an independent consultant in healthcare safety during a Feb. 24 webinar on the potential use of health IT to mitigate rehospitalizations, sponsored by the Agency for Healthcare Research and Quality (AHRQ).
During the Health IT Standards Committee meeting on Feb. 24 in Washington, D.C., the Clinical Operations Workgroup sought to gather comments on proposed recommendations on implementation specifications for content exchange, vocabulary and code set standards for the Interim Final Rule of meaningful use.
In 2006, the Center for Devices and Radiological Health (CDRH), a branch of the FDA, began examining the number of medical device reports they received. Over the past two years, the number of submitted reports has increased, sparking a demand for the CDRH to make a move to electronic reporting.
A new hospital breaking ground usually isn’t breaking news. But the vision of patient care at one new facility, tentatively named Palomar Medical Center West (PMC West), is currently illegal under California state law.